Older, out-of-school and anonymous partners pose more HIV infection risk for adolescent girls in South Africa
The fight for access to abortion care in Europe
Cases of hair loss among African-American women reported after switch to new tenofovir formula
Study illuminates PrEP treatment pathway and its facilitators and barriers for women in the Bronx
Older black HIV-positive women have more mental distress than other women with HIV, but get less help for it
Raltegravir plus lamivudine is likely to work as PrEP
TAF: Quick-dissolve combination PrEP insert is effective against HIV infections in monkeys; intermittent solo pill less so
People stay on PrEP for 14 months on average in the US, study finds
Women with HIV may have higher breast cancer mortality
